CIRCUMVENT® CL
The first and only combination vaccine shown to be effective for the vaccination of healthy swine three weeks of age or older against disease caused by Porcine Circovirus Types 2a and 2d, and Lawsonia intracellularis.
LEARN MORECIRCUMVENT® PCV-M G2
For the vaccination of healthy swine against Porcine Circovirus (Type 2) and Mycoplasma hyopneumoniae.
LEARN MOREMU-SE®
For the treatment of Selenium-tocopherol deficiency syndrome (white muscle disease) in weanling calves and breeding beef cattle.
LEARN MORECIRCUMVENT® PCV G2
For the vaccination of healthy swine against Porcine Circovirus (Type 2).
LEARN MORECIRCUMVENT® CML
For the vaccination of healthy swine against disease caused by Porcine Circovirus (Types 2a and 2d), Mycoplasma hyopneumoniae…
LEARN MOREBOVILIS® VL5 SQ
For the vaccination of healthy cattle 6-months or older against reproductive disease caused by Campylobacter fetus and leptospirosis.
LEARN MOREBOVILIS® L5 SQ
For the vaccination of healthy cattle 6-months and older for preventing leptospirosis and prevention of urinary shedding of L. hardjo organisms.
LEARN MOREBOVILIS® J-5
For vaccination of healthy adult cattle, including pregnant cattle, against mastitis due to Escherichia coli.
LEARN MOREBOVILIS® CORONAVIRUS
Intranasal vaccine shown to be effective for the vaccination of healthy calves against enteric disease caused by bovine coronavirus.
LEARN MOREBANAMINE®-S (flunixin meglumine injection)
For the control of pyrexia associated with swine respiratory disease.
LEARN MOREBANAMINE® TRANSDERMAL
Indicated for the control of fever associated with BRD, bovine mastitis and pain associated with foot rot. The first and only NSAID cattle…
LEARN MOREBANAMINE® (flunixin meglumine paste)
BANAMINE® (flunixin meglumine paste) is a trusted and effective treatment for musculoskeletal disorders in horses. Learn more about its uses.
LEARN MORE
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global